Aspirin non-medicine is risky for long-term use January 28, 2019 Source: Science and Technology Daily Author: Hu Dingkun In recent years, the idea that aspirin is a “medicinal medicine†that can prevent heart disease and even reduce the risk of cancer is rampant. Recently, the Journal of the American Medical Association pointed out that long-term use of aspirin increases the probability of internal bleeding, and the side effects even exceed the preventive effect of cardiovascular disease. The article analyzes the results of 10 previous studies involving a total of 164,000 people with an average age of 62 years. The researchers compared those taking aspirin with those who did not take aspirin, and found that the number of people suffering from stroke, heart disease and other diseases did decrease, but the incidence of internal bleeding in the brain, stomach, and intestines also increased. According to statistics, for every 10,000 people who do not have heart disease and do not take aspirin within one year, 61 people will have heart attack or stroke attack; and 10,000 people who have no heart disease and take aspirin for one year, 57 people will suffer. Vascular disease. Long-term use of aspirin can only reduce the incidence of cardiovascular disease by four-tenths. However, out of every 10,000 people taking aspirin, 23 had severe internal bleeding; only 17 of those who did not take aspirin, the incidence of internal bleeding increased by 6%. In addition, the article also explored the preventive effect of aspirin on cancer. The article pointed out that a study found that after 5 years of follow-up, the use of aspirin reduced cancer mortality by 15%; but in the second follow-up experiment of nearly 500 patients for 7 years, did not get similar the result of. This suggests that aspirin has no effect on the incidence of cancer. At present, there is controversy about whether healthy people should take aspirin to prevent cardiovascular disease. According to a national survey of adults in the United States, about half of people regularly take aspirin. The US Preventive Services Task Force recommends that "low-dose aspirin is used in patients with primary disease prevention for cardiovascular disease and colorectal cancer between the ages of 50 and 59. The risk of cardiovascular disease and colorectal cancer in these patients For more than 10%, the risk of bleeding is not high and the life expectancy is at least 10 years." The UK does not recommend taking aspirin to prevent cardiovascular disease. Pearson, deputy director of the British Heart Foundation, pointed out that the study confirmed that the side effects of aspirin exceeded the preventive function, so the UK should not change the guidelines. YT-60 YT-60 Shenzhen Sunshine Technology Co.,Ltd , https://www.szyatwin.com